| Literature DB >> 35049874 |
Mahnaz Mohammadpour1, Hadi Samadian2, Nader Moradi3, Zhila Izadi2, Mahdieh Eftekhari2, Masoud Hamidi4, Amin Shavandi4, Anthony Quéro5, Emmanuel Petit5, Cédric Delattre6,7, Redouan Elboutachfaiti5.
Abstract
In the current paper, we fabricated, characterized, and applied nanocomposite hydrogel based on alginate (Alg) and nano-hydroxyapatite (nHA) loaded with phenolic purified extracts from the aerial part of Linum usitatissimum (LOH) as the bone tissue engineering scaffold. nHA was synthesized based on the wet chemical technique/precipitation reaction and incorporated into Alg hydrogel as the filler via physical cross-linking. The characterizations (SEM, DLS, and Zeta potential) revealed that the synthesized nHA possess a plate-like shape with nanometric dimensions. The fabricated nanocomposite has a porous architecture with interconnected pores. The average pore size was in the range of 100-200 µm and the porosity range of 80-90%. The LOH release measurement showed that about 90% of the loaded drug was released within 12 h followed by a sustained release over 48 h. The in vitro assessments showed that the nanocomposite possesses significant antioxidant activity promoting bone regeneration. The hemolysis induction measurement showed that the nanocomposites were hemocompatible with negligible hemolysis induction. The cell viability/proliferation confirmed the biocompatibility of the nanocomposites, which induced proliferative effects in a dose-dependent manner. This study revealed the fabricated nanocomposites are bioactive and osteoactive applicable for bone tissue engineering applications.Entities:
Keywords: Linum usitatissimum phenolics extract; alginate hydrogel; nano-hydroxyapatite; nanocomposite; tissue engineering
Mesh:
Substances:
Year: 2021 PMID: 35049874 PMCID: PMC8781792 DOI: 10.3390/md20010020
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Scheme 1General scheme for synthesis route of the Alginate/nHA/LOH nanocomposite gels.
Figure 1XRD pattern of the synthesized nHA.
Figure 2SEM micrographs of (A) pure Alg, and cross-linked Alg/LOH/nHA nanocomposite with different contents of nHA (B) 7% nHA, (C) 14% nHA, and (D) 21% nHA. High magnification SEM image of the cross section indicating the nHA crystals. The scale bars in Figures (A–D) are 300 μm, the scale bare in the magnified Figures are 5 μm.
Figure 3EDX spectrum of the Alg/LOH/nHA cross-linked polymer on double-sided adhesive carbon tape.
Figure 4FTIR spectra of synthesized Alg/LOH/nHA nanocomposite compared to pure Alg, nHA, and LOH.
Figure 5The effect of nHA content on the swelling rate of Alg/LOH/nHA nanocomposite hydrogel.
The EE% and LC% of LOH-loaded cross-linked hydrogel for LOH.
| Group | Entrapment Efficacy (%) | Loading Capacity (%) |
|---|---|---|
| Alg/LOH/nHA 7% | 55.07 | 1.47 |
| Alg/LOH/nHA 14% | 61.47 | 1.71 |
| Alg/LOH/nHA 21% | 63.66 | 1.80 |
Figure 6Cumulative release profiles of the Alg/LOH/nHA 21% nanocomposite gel in deionized water and pH 7.2 PBS.
Figure 7Assessment of hemolytic potential of the Alg/LOH/nHA in compared positive control after 1 h incubation with diluted blood with PBS. H2O and PBS are the positive and negative controls, respectively.
Figure 8The antioxidant activity of LOH and ascorbic acid.
Figure 9Proliferation of MG63 cells on the prepared nanocomposite hydrogels measured by the MTT assay. Mean ± SD, *: p < 0.05.